Oragenics Announces Positive Data on Intranasal COVID-19 Vaccine Candidate
American biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe first doses of an experimental HIV vaccine antigen have been provided in a clinical study at George Washington University
Read moreThe U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read morePfizer and BioNTech announced on Tuesday that a clinical trial in healthy people 18 to 55 years old to assess
Read moreBased on data obtained from Phase II and the Phase I studies, Abecma has received approval in Japan for the
Read moreThe novel 3DProSeed ® StromaLine ® developed by Ectica is an advantageous collection of pre-developed and well characterized stromal models
Read moreFrench pharma giant Sanofi and British pharmatech business Exscientia revealed a ground-breaking research cooperation and licensing agreement to develop up
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read morePfizer’s COVID-19 Antiviral, PAXLOVID, has been authorised for use in people over 18 with mild to moderate COVID-19 and at
Read moreThe award-winning Ireland-based medical device company Aerogen and the innovative Chinese vaccine company CanSinoBIO entered into a partnership earlier this
Read more